Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex, Eurofins, Phenomenex Collaborate on Animal Feed Analysis

NEW YORK (GenomeWeb News) – Eurofins Scientific, AB Sciex, and Phenomenex are collaborating to develop methods to detect the presence of antibiotic and fungicide residue in animal feed.

The initial result of the deal, which was announced today, is an application for analyzing up to nine antibiotics and four insecticides in poultry feeds, covering five antibiotic drug classes.

In a statement, the firms noted that the use of antibiotics in animals can make their way into the food supply for humans, potentially contributing to an increase in antibiotic-resistant microorganisms. Insecticides and pesticides may also be prevalent in animal feeds.

"For a food testing lab, feeds are a notoriously challenging matrix to analyze," John Reuther, president of Eurofins CAL, Eurofins' US Competence Center for Residue and Contaminant Analysis, said in a statement. "By taking a leadership role in the food testing community, we are delivering robust and reliable methods not only to improve the analysis of animal feed but also to provide the best solutions to help our customers in the food and feed industries effectively address the growing industry demands of improved product quality and safety.

"Working together with AB Sciex and Phenomenex gives us the technological capabilities to successfully execute our residue test methods, which ultimately help protect the global food supply," Reuther added.

AB Sciex, a Danaher company, has been developing food testing methods for more than a decade and along with Phenomenex and Eurofins will seek to "improve the accuracy of results at the lowest possible levels of detection in these increasingly complex mixtures," the companies said.

Financial and other terms of the collaboration were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.